Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 30Gastrointestinal 10Genitourinary 8Breast 6Gynecologic 3Other solid neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 9Hematopoietic and Lymphatic System Neoplasm 5Hematopoietic and Lymphoid System Neoplasm 4Malignant Solid Neoplasm 3Unspecified Childhood Solid Tumor, Protocol Specific 2Advanced Malignant Solid Neoplasm 2Thymoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Mesothelioma, Malignant 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 6pembrolizumab 5Cisplatin 4sargramostim 3Pemetrexed 3Decitabine 3Celecoxib 3fludarabine 2belinostat 2SS1(dsFv)PE38 2Quality of Life 2Plicamycin 2Nivolumab 2Ipilimumab 2FANG vaccine 2Drug Therapy 2perflutren 1olaparib 1niraparib 1iodixanol 1incomplete Freund's adjuvant 1fludarabine phosphate 1dostarlimab 1anetumab ravtansine 1aldesleukin 1alanosine 1Vorinostat 1Valacyclovir 1UV1 vaccine 1Tumor Burden 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Early Intervention, Educational × Other solid neoplasm × Clear all
NCT00372840 2020-03-02

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Fox Chase Cancer Center

Phase NA Completed
340 enrolled
BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Thymoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡